Skip to content
Open access

Detection of Lipid-Mediated Diffused Pathological Changes in Multiple Sclerosis

Aug 2026 · Research Square · 0 citations · 51 references
Medicine

TL;DR

Reduced tNOE contrast corresponded with known regional differences in myelin density and suggests sensitivity to myelin-integrity, and shows promise as a rapid biomarker for MS diagnosis.

Abstract

Background Lipid dysregulation and myelin breakdown are hallmark features of multiple sclerosis (MS), yet current noninvasive biomarkers have limited sensitivity for detecting both focal demyelination and diffuse microstructural injury. We evaluated transient nuclear Overhauser effect (tNOE) MRI, a lipid-sensitive imaging technique, for mapping myelin-related alterations in MS. Methods tNOE-MRI was performed in four MS patients and four healthy controls using a 7T scanner equipped with a 32-channel receive phased-array coil. Scan reproducibility was assessed across repeated sessions, and tNOE signal patterns were analyzed in major white-matter regions, including corpuscallosum and internal-capsule. Results tNOE maps demonstrated strong contrast in highly myelinated structures, like splenium of corpuscallosum and internal-capsule. Inter-day and intra-day coefficients of variation were < 5%, indicating high measurement consistency. Quantitative analysis revealed that MS patients had significantly lower tNOE contrast in white-matter (12.6%vs16.1%) and grey-matter (5.9%vs7.2%) compared to healthy controls. The splenium exhibited the greatest tNOE reduction (~ 36%) in MS. Discussion Reduced tNOE contrast corresponded with known regional differences in myelin density and suggests sensitivity to myelin-integrity. Lower tNOE signals in both white and gray matter indicate diffuse tissue alterations beyond focal lesions. With an acquisition time of ~ 3 minutes, tNOE-MRI shows promise as a rapid biomarker for MS diagnosis.

Read PDF

Similar papers

Review Open access Sep 2026

MRI-based white matter microstructural and neurochemical alterations in multiple sclerosis: a systematic review

DTI and MRS demonstrate complementary WM microstructural and neurochemical alterations in MS and examine the reported associations between DTI-derived diffusion metrics and MRS-derived metabolic markers.

Dheeraj Kumar, Shivam Agrawal, Rajul Rastogi et al. · 0 citations
Open access Sep 2026

Neurometabolic brain changes in MS associated with fatigue and anxiety.

BACKGROUND Multiple sclerosis (MS) is a disease characterised by progressive neurodegeneration and demyelination, manifesting as focal white matter lesions (WML) and extending into normal-appearing white matter (NAWM) and grey matter (NAGM). In this exploratory, hypothesis-generating study, we investigated regional neu...

Ibrahim Khormi, O. Al-iedani, Amir Fazlollahi et al. · 0 citations
Open access Aug 2026

Preserved neurovascular coupling in early multiple sclerosis is associated with reduced white matter lesion burden

Preserved PCA neurovascular function is associated with lower WM lesion burden, measured using conventional MRI, in MS patients with lower disability and better cognition, a finding that may inform risk stratification and guide future therapeutic targets.

C. Duque, J. Sargento-Freitas, Roumen Balabanov et al. · 0 citations
Review Sep 2026

MRI Characteristics of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review.

Importance Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a demyelinating disease distinct from multiple sclerosis (MS) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD). Magnetic resonance imaging (MRI) is central to confirming attacks, defining lesion di...

E. Flanagan, Brenda L. Banwell, Laura Cacciaguerra et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.